Mostrando resultados 7 a 11 de 11
< Anterior
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 2018 | Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study | Mohty, Mohamad; Terpos, Evangelos; Mateos, Maria Victoria; Cavo, Michele; Lejniece, Sandra; Beksac, Meral; Amine Bekadja, Mohamed; Legiec, Wojciech; Dimopoulos, Meletios A.; Stankovic, Svetlana; Durán, Maria Soledad; Stefano, Valerio De; Corso, Alessandro; Kochkareva, Yulia; Laane, Edward; Berthou, Christian; Salwender, Hans; Masliak, Zvenyslava; Pečeliūnas, Valdas; Willenbacher, Wolfgang; Silva, João; Louw, Vernon; Nemet, Damir; Borbényi, Zita; Abadi, Uri; Schou Pedersen, Robert; Černelč, Peter; Potamianou, Anna; Couturier, Catherine; Feys, Caroline; Thoret-Bauchet, Florence; Boccadoro, Mario | artículo |
| closedAccess |  | 2019 | Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial | Dimopoulos, Meletios A.; Gay, Francesca; Schjesvold, Fredrik; Beksac, Meral; Hajek, Roman; Weisel, Katja C.; Goldschmidt, Hartmut; Maisnar, Vladimir; Moreau, Philippe; Ki Min, Chang; Pluta, Agnieszka; Chng, Wee-Joo; Kaiser, Martin; Zweegman, Sonja; Mateos, Maria Victoria; Spencer, Andrew; Iida, Shinsuke; Morgan, Gareth J.; Suryanarayan, Kaveri; Teng, Zhaoyang; Skacel, Tomas; Palumbo, Antonio; Dash, Ajeeta B.; Gupta, Neeraj; Labotka, Richard; Rajkumar, S. Vincent | artículo |
| openAccess |  | mar-2023 | Overall Survival with Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial | Sonneveld, Pieter; Chanan-Khan, Asher A.; Weisel, Katja C.; Nooka, Ajay; Masszi, Tamas; Beksac, Meral; Špička, Ivan; Hungria, Vania; Munder, Markus; Mateos, Maria Victoria; Mark, Tomer M.; Levin, Mark-David; Ahmadi, Tahamtan; Qin, Xiang; Garvin Mayo, Wendy; Gai, Xue; Carey, Jodi; Carson, Robin; Spencer, Andrew | artículo |
| closedAccess | | abr-2022 | Supplementary files of the article Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial [Dataset] | Terpos, Evangelos; Dimopoulos, Meletios A.; Boccadoro, Mario; Delimpasi, Sosana; Beksac, Meral; Katodritou, Eirini; Moreau, Philippe; Pompa, Alessandra; Symeonidis, Argiris; Bila, Jelena; Oriol, Albert; Mateos, Maria Victoria; Einsele, Hermann; Orfanidis, Ioannis; Gries, Katharine S.; Fastenau, John; Liu, Kevin; He, Jianming; Kampfenkel, Tobias; Qiu, Yanping; Amin, Himal; Carson, Robin; Sonneveld, Pieter | dataset |
| closedAccess | | jul-2023 | Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma | Mateos, Maria Victoria; Rigaudeau, Sophie; Basu, Supratik; Špička, Ivan; Schots, Rik; Wrobel, Tomasz; Cook, Gordon; Beksac, Meral; Gries, Katharine S.; Kudva, Anupa; Tromp, Brenda; Rampelbergh, Rian Van; Pei, Huiling; Wroblewski, Susan; Carson, Robin; Delioukina, María; White, Darrell | artículo |
